Product Overview The Epiomic™ segmentation database: - TopicsExpress



          

Product Overview The Epiomic™ segmentation database: bit.ly/14VplKi What is it? For business analyst and healthcare industry professionals, the Epiomic™ segmentation database provides a robust, evidence-based source for patient populations that go beyond basic prevalence or incidence, to include essential conditions and patient attributes for each disease. By overlaying the basic prevalence, or incidence data, with patient vital signs, pathophysiology and co-morbidities, more accurate patient segmentation is possible. These refined populations provide the building blocks for robust product valuations and forecasts for new healthcare innovations. The patient populations can be separated by the 6 leading global pharmaceutical markets, or combined for US and Top 5 EU regional totals. The markets available for each disease include: • United States • France • Germany • Italy • Spain • United Kingdom What distinguishes the Epiomic™ segmentation database from all others? • Quality – utilising the most currently available data from patient registries, clinical trials and epidemiology studies to generate accurate patient population estimates • Breadth & depth – covering over 125 distinct diseases including over 2,500 unique sub-populations, displaying many of the clinically critical attributes and co-morbid conditions seen in these patients • Flexibility – enabling user to select the disease data over a 25-year outlook period cut by gender, 5-year age cohorts and user specified biometrics distributions (e.g. BMI, kidney function, blood pressure) • User friendly – intuitive customer interface that makes it simple to navigate through the site and between different diseases and sub-populations. • Ease of use – ability to import the data in your company’s specific format or ability to use one of the generic chart templates commonly used in the pharma industry • Bespoke – opportunity to obtain specific data for a particular disease on a one-off ad hoc basis without requiring a subscription It will provide timely insight. It will create a competitive advantage.
Posted on: Sun, 04 Aug 2013 14:46:50 +0000

Trending Topics



Recently Viewed Topics




© 2015